AngioDynamics Inc at JPMorgan Healthcare Conference Transcript
Good morning, all, and thank you for joining us today. My name is Caroline Borowski, and I'm a team member here at the JPMorgan Healthcare Group. It is my pleasure to introduce Jim Clemmer, President and CEO of AngioDynamics.
Great. Thank you, and thanks for joining us this morning. I appreciate the great conference that JPMorgan is hosting this week.
So let me talk to you a little bit about our company. Before I begin, I'll remind our investors to check our forward-looking statements. Remember that everything we've shared with you today are our best projections, strategies and direction for our company and how we'll create value going forward. But as savvy investors know, we can't guarantee you anything, so please do your research and learn about our company in more detail.
So let's start off with talking about AngioDynamics. So we're a diverse company that's now focused our energy and our efforts towards 4 disease states that we'll spend a few minutes sharing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
